TW200632319A - Ex vivo cancer diagnostic method - Google Patents

Ex vivo cancer diagnostic method

Info

Publication number
TW200632319A
TW200632319A TW094140510A TW94140510A TW200632319A TW 200632319 A TW200632319 A TW 200632319A TW 094140510 A TW094140510 A TW 094140510A TW 94140510 A TW94140510 A TW 94140510A TW 200632319 A TW200632319 A TW 200632319A
Authority
TW
Taiwan
Prior art keywords
diagnostic method
alkaloid
cancer diagnostic
diagnostic
vivo cancer
Prior art date
Application number
TW094140510A
Other languages
English (en)
Chinese (zh)
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of TW200632319A publication Critical patent/TW200632319A/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW094140510A 2004-11-19 2005-11-18 Ex vivo cancer diagnostic method TW200632319A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04027575 2004-11-19

Publications (1)

Publication Number Publication Date
TW200632319A true TW200632319A (en) 2006-09-16

Family

ID=35827559

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094140510A TW200632319A (en) 2004-11-19 2005-11-18 Ex vivo cancer diagnostic method

Country Status (3)

Country Link
AR (1) AR051502A1 (fr)
TW (1) TW200632319A (fr)
WO (1) WO2006053680A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007073919A2 (fr) * 2005-12-28 2007-07-05 Nowicky Wassili Procede de detection du cancer
WO2007107334A1 (fr) * 2006-03-20 2007-09-27 Nowicky Wassili Procédé de diagnostic du cancer ex vivo
CN103270168A (zh) * 2010-12-24 2013-08-28 爱科来株式会社 癌细胞的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US5399338A (en) * 1991-05-01 1995-03-21 University Of New Mexico Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy
FR2694193B1 (fr) * 1992-07-28 1994-10-28 Abraxas Bio Labs Sa Méthode de cytodiagnostic utilisant l'alstonine comme marqueur sélectif et kit de diagnostic contenant ce marqueur.
CA2337690C (fr) * 1998-07-27 2013-10-01 Texas Pharmaceuticals, Inc. Hyperthermie intracellulaire induite chimiquement
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.

Also Published As

Publication number Publication date
WO2006053680A1 (fr) 2006-05-26
AR051502A1 (es) 2007-01-17

Similar Documents

Publication Publication Date Title
IL180896A0 (en) Method of tumour imaging
WO2007015947A3 (fr) Methodes et trousses pour la prediction du succes therapeutique, de la survie sans recidive et globale dans des therapies du cancer
WO2005044091A3 (fr) Methodes diagnostiques et therapeutiques et compositions impliquant des pten et le cancer du sein
WO2006015079A3 (fr) Agents de liaison de la famille erm et leur utilisation dans le diagnostic et le traitement d'etats proliferatifs
WO2005008248A3 (fr) Diagnostique et traitement du cancer des cervicales
WO2008103645A3 (fr) Antigènes spécifiques du cancer de la prostate et du mélanome
WO2005010213A3 (fr) Marqueurs pour la detection du cancer de l'estomac
DE69907151D1 (de) Krebsbehandlung
WO2007109236A8 (fr) Empreintes digitales micro-arn pendant une mégacaryocytopoïese
ATE480776T1 (de) Tumorassoziierte antigenprofile in der krebsdiagnostik und immuntherapie
EP1892306A3 (fr) Méthode et trousses pour évaluer un cancer
WO2007033167A3 (fr) Compositions et methodes de detection et de traitement du cancer
TW200632319A (en) Ex vivo cancer diagnostic method
WO2004100998A3 (fr) Compositions et procedes de visualisation non effractive du beta-amyloide soluble
WO2005030266A3 (fr) Imagerie optique du cancer colorectal
WO2006088940A3 (fr) Compositions de depistage de neoplasie et procedes d'utilisation
MX2007005501A (es) Asociacion tumoral de mieloide de lectina-1 asociada a dap12 y metodos.
WO2005034926A3 (fr) Systeme non-effractif de detection de cancer de la peau
WO2010026473A3 (fr) Proteine pta072
WO2002023200A3 (fr) Biomarqueurs humains du cancer du sein
WO2006038212A3 (fr) Methodes et compositions de diagnostic et de traitement du cancer
AU2001294165A1 (en) Apparatus for prostate cancer diagnose
WO2004041196A3 (fr) Procedes et compositions pour le diagnostic du cancer du poumon neuroendocrinien
WO2001004343A3 (fr) Procede permettant d'etablir un pronostic pour des patients atteints d'un cancer, par mesure des niveaux d'expression de la proteine bag
MY147511A (en) Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage-a3-marker